Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque
Open Access
- 20 December 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1816
Abstract
Objectives: Anti-citrullinated peptides antibodies (ACPAs) have high specificity for the diagnosis of rheumatoid arthritis (RA), but their role in the pathophysiology is not fully established. The main genetic risk factor for RA, the shared epitope in major histocompatibility complex class II, is associated with ACPAs. Among certain non-human primates, 8% carry the shared epitope called H6 haplotype, and being similar to humans, are ideal candidates to study the role of ACPAs in RA. The goal of this study was to develop a macaque model of RA based on immunization against citrullinated peptides to generate an ACPA-mediated model of arthritis. Methods: Cynomolgus macaques were immunized with four citrullinated peptides from vimentin, fibrinogen, and aggrecan, known to induce T-cell response in RA patients, and received an intra-articular (IA) boost with the same four citrullinated peptides pooled. Results: In the macaque, the T-cell response was specific to citrullinated peptides. Antibodies generated in response to immunization were cross-reactive between the citrulline and arginine peptides. The presence of the H6 haplotype did not affect the magnitude of the immune response. Since no clinical response was observed, macaques received an IA boost with the same four peptides pooled and incomplete Freund’s adjuvant, which led to a prolonged neutrophil-rich mono-arthritis, preferentially in H6-positive animals. Conversely, animals boosted with incomplete Freund’s adjuvant alone presented only transient mono-arthritis. Conclusion: This two-hit model of prolonged mono-arthritis mimics what could happen in RA. Despite the limited number of joints with disease in the macaque model, the model appears unique to study the events occurring during the preclinical phase of RA, from immunization against citrullinated peptides to the clinical appearance of disease.Keywords
This publication has 29 references indexed in Scilit:
- NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid ArthritisScience Translational Medicine, 2013
- T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope allelesArthritis Research & Therapy, 2012
- Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsArthritis & Rheumatism, 2011
- Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patientsArthritis & Rheumatism, 2009
- Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritisArthritis & Rheumatism, 2009
- Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic miceJournal of Experimental Medicine, 2008
- Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaquesImmunogenetics, 2007
- Epitopes of human fibrin recognized by the rheumatoid arthritis‐specific autoantibodies to citrullinated proteinsEuropean Journal of Immunology, 2006
- Influence of HLA–DR genes on the production of rheumatoid arthritis–specific autoantibodies to citrullinated fibrinogenArthritis & Rheumatism, 2005
- Collagen‐induced arthritis in an outbred group of rhesus monkeys comprising responder and nonresponder animals. Relationship between the course of arthritis and collagen‐specific immunityArthritis & Rheumatism, 1991